- Home
- BSBK vs ANIX Comparison
BSBK vs ANIX Comparison
Compare BSBK & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBK | ANIX |
|---|---|---|
| Founded | 1893 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.1M | 104.0M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | BSBK | ANIX |
|---|---|---|
| Price | $8.42 | $3.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 5.5K | ★ 235.2K |
| Earning Date | 02-13-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $15,989,970.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $228.58 | ★ N/A |
| Revenue Growth | ★ 31.80 | N/A |
| 52 Week Low | $6.59 | $2.28 |
| 52 Week High | $9.50 | $5.46 |
Technical Indicators
Market Signals| Indicator | BSBK | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 38.84 |
| Support Level | $8.44 | $3.07 |
| Resistance Level | $8.64 | $3.36 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 32.87 | 9.62 |
Price Performance
Historical ComparisonAbout BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.